$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta

$lsta Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000032001715000077 Filed on November 05, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q4
Revenue	$7.560K	$5.888M	$5.276K
YoY Change	43.29%	142892.96%	29.38%
Cost Of Revenue	$6.230M	$4.809M	$4.210M
YoY Change	47.98%	19.85%	24.19%
Gross Profit	$1.330M	$1.080M	$1.070M
YoY Change	24.3%	-126.94%	55.07%
Gross Profit Margin	17592.59%	18.34%	20280.52%
Selling, General & Admin	$4.990M	$5.147M	$6.450M
YoY Change	-22.64%	-34.8%	9.51%
% of Gross Profit	375.19%	476.69%	602.8%
Research & Development	$3.150M	$6.316M	$10.14M
YoY Change	-68.93%	-25.43%	91.68%
% of Gross Profit	236.84%	584.9%	947.66%
Depreciation & Amortization	$800.0K	$640.0K	$610.0K
YoY Change	31.15%	8.47%	48.78%
% of Gross Profit	60.15%	59.27%	57.01%
Operating Expenses	$8.170M	$16.27M	$16.62M
YoY Change	-50.84%	-20.15%	48.66%
Operating Profit	-$6.840M	-$10.38M	-$15.55M
YoY Change	-56.01%	-36.14%	48.24%
Interest Expense	-$480.0K	$553.0K	-$370.0K
YoY Change	29.73%	201.39%	428.57%
% of Operating Profit
Other Income/Expense, Net	$13.32M	-$963.2K	$3.990M
YoY Change	233.83%	10.62%	-314.52%
Pretax Income	-$33.23K	-$11.35M	-$11.69K
YoY Change	184.22%	-33.76%	-8.08%
Income Tax	-$13.63M	$46.63K	-$250.0K
% Of Pretax Income
Net Earnings	-$33.20K	-$11.38K	-$11.61K
YoY Change	185.89%	-32.98%	-7.36%
Net Earnings / Revenue	-439.11%	-0.19%	-220.09%
Basic Earnings Per Share
Diluted Earnings Per Share	-$5.887M	-$2.062M	-$3.225M
COMMON SHARES
Basic Shares Outstanding	55.37M shares	55.35M shares	35.74M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.66M	$29.39M	$26.25M
YoY Change	-28.93%	-10.41%	-43.09%
Cash & Equivalents	$18.66M	$24.04M	$19.17M
Short-Term Investments	$0.00	$5.349M	$7.080M
Other Short-Term Assets	$6.400M	$6.700M	$6.900M
YoY Change	-7.25%	3.08%	137.93%
Inventory
Prepaid Expenses
Receivables	$2.566M	$2.300M	$3.111M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$29.27M	$38.48M	$36.28M
YoY Change	-19.32%	-7.08%	-28.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.06M	$17.10M	$15.96M
YoY Change	6.92%	8.98%	24.26%
Goodwill	$7.000M	$25.21M	$25.21M
YoY Change	-72.23%	0.0%	126.75%
Intangibles	$2.878M	$37.71M	$47.56M
YoY Change	-93.95%	-20.97%	242.76%
Long-Term Investments
YoY Change
Other Assets	$976.8K	$1.210M	$1.263M
YoY Change	-22.69%	-8.16%	9.69%
Total Long-Term Assets	$27.93M	$81.22M	$89.99M
YoY Change	-68.96%	-9.68%	130.82%
TOTAL ASSETS
Total Short-Term Assets	$29.27M	$38.48M	$36.28M
Total Long-Term Assets	$27.93M	$81.22M	$89.99M
Total Assets	$57.21M	$119.7M	$126.3M
YoY Change	-54.7%	-8.86%	40.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.107M	$2.467M	$5.661M
YoY Change	-27.45%	-43.94%	68.74%
Accrued Expenses	$6.198M	$8.011M	$4.323M
YoY Change	43.39%	184.22%	7.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$4.171M	$2.751M	$1.110M
YoY Change	275.94%	175.14%
Total Short-Term Liabilities	$21.02M	$19.74M	$16.24M
YoY Change	29.37%	66.52%	65.64%
LONG-TERM LIABILITIES
Long-Term Debt	$10.83M	$12.25M	$13.89M
YoY Change	-22.04%	-18.34%
Other Long-Term Liabilities	$562.0K	$3.457M	$804.5K
YoY Change	-30.15%	461.28%	34.38%
Total Long-Term Liabilities	$33.92M	$15.71M	$68.20M
YoY Change	-50.26%	0.58%	145.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.02M	$19.74M	$16.24M
Total Long-Term Liabilities	$33.92M	$15.71M	$68.20M
Total Liabilities	$33.92M	$64.71M	$68.20M
YoY Change	-50.26%	-6.6%	145.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$372.1M	-$338.9M	-$291.2M
YoY Change	27.77%	21.21%	23.21%
Common Stock	$5.673K	$55.50K	$36.78K
YoY Change	-84.58%	56.39%	35.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$707.6K	$705.7K	$705.7K
YoY Change	0.27%	0.0%	0.0%
Treasury Stock Shares	11.00K shares
Shareholders Equity	$23.71M	$55.43M	$58.51M
YoY Change
Total Liabilities & Shareholders Equity	$57.21M	$119.7M	$126.3M
YoY Change	-54.7%	-8.86%	40.59%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q4
OPERATING ACTIVITIES
Net Income	-$33.20K	-$11.38K	-$11.61K
YoY Change	185.89%	-32.98%	-7.36%
Depreciation, Depletion And Amortization	$800.0K	$640.0K	$610.0K
YoY Change	31.15%	8.47%	48.78%
Cash From Operating Activities	-$8.730M	-$8.700M	-$10.91M
YoY Change	-19.98%	-35.46%	48.23%
INVESTING ACTIVITIES
Capital Expenditures	-$620.0K	-$770.0K	-$730.0K
YoY Change	-15.07%	57.14%	-58.05%
Acquisitions
YoY Change
Other Investing Activities	$5.330M	-$2.390M	-$6.460M
YoY Change	-182.51%	-1056.0%
Cash From Investing Activities	$4.720M	-$3.150M	-$7.190M
YoY Change	-165.65%	1212.5%	313.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	280.0K	-310.0K	5.120M
YoY Change	-94.53%	-102.38%	-86.63%
NET CHANGE
Cash From Operating Activities	-8.730M	-8.700M	-10.91M
Cash From Investing Activities	4.720M	-3.150M	-7.190M
Cash From Financing Activities	280.0K	-310.0K	5.120M
Net Change In Cash	-3.730M	-12.16M	-12.98M
YoY Change	-71.26%	1588.89%	-144.47%
FREE CASH FLOW
Cash From Operating Activities	-$8.730M	-$8.700M	-$10.91M
Capital Expenditures	-$620.0K	-$770.0K	-$730.0K
Free Cash Flow	-$8.110M	-$7.930M	-$10.18M
YoY Change	-20.33%	-38.95%	81.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Cost Of Revenue CostOfRevenue	13976087	USD
	clbs	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	3147091	USD
CY2014Q4	clbs	Aggregate Intrinsic Value Warrants Outstanding AggregateIntrinsicValueWarrantsOutstanding	1000	USD
CY2015Q3	clbs	Aggregate Intrinsic Value Warrants Outstanding AggregateIntrinsicValueWarrantsOutstanding	0	USD
CY2015Q3	clbs	Aggregate Intrinsic Value Warrantsvested AggregateIntrinsicValueWarrantsvested	0	USD
CY2015Q3	clbs	Aggregate Intrinsic Value Warrantsvestedandexpectedtovest AggregateIntrinsicValueWarrantsvestedandexpectedtovest	0	USD
	clbs	Changein Ownershipin Subsidiary ChangeinOwnershipinSubsidiary	0	USD
	clbs	Changein Ownershipin Subsidiary ChangeinOwnershipinSubsidiary	0	USD
CY2014Q3	clbs	Clinical Services Reimbursement ClinicalServicesReimbursement	1000000	USD
	clbs	Clinical Services Reimbursement ClinicalServicesReimbursement	2800000	USD
CY2015Q3	clbs	Clinical Services Reimbursement ClinicalServicesReimbursement	900000	USD
	clbs	Clinical Services Reimbursement ClinicalServicesReimbursement	2300000	USD
CY2014Q4	clbs	Common Stock Warrants Shares CommonStockWarrantsShares	3550956	shares
CY2015Q3	clbs	Common Stock Warrants Shares CommonStockWarrantsShares	3516452	shares
	clbs	Commonstockandcontingentconsiderationissuedinmerger Commonstockandcontingentconsiderationissuedinmerger	33490351	USD
	clbs	Commonstockandcontingentconsiderationissuedinmerger Commonstockandcontingentconsiderationissuedinmerger	0	USD
	clbs	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-2483740	USD
CY2011Q4	clbs	Percentageof Net Sales PercentageofNetSales	0.10
CY2011Q4	clbs	Percentageoflicensecost Percentageoflicensecost	0.30
CY2014Q4	clbs	Preferred Stock Shares Designated PreferredStockSharesDesignated	825000	shares
CY2015Q3	clbs	Preferred Stock Shares Designated PreferredStockSharesDesignated	825000	shares
	clbs	Provision For Reduction Of Doubtful Accounts ProvisionForReductionOfDoubtfulAccounts	5763	USD
	clbs	Provision For Reduction Of Doubtful Accounts ProvisionForReductionOfDoubtfulAccounts	3774	USD
CY2015Q3	clbs	Sharesvestedandexpectedtovest Sharesvestedandexpectedtovest	3516452	shares
	clbs	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	1720725	USD
CY2015Q3	clbs	Subsidiary Ownership Interest By Parent SubsidiaryOwnershipInterestByParent	0.970
	clbs	Warrants Canceled WarrantsCanceled	34504	shares
	clbs	Warrants Exercised WarrantsExercised	0	shares
	clbs	Warrants Expired WarrantsExpired	0	shares
	clbs	Warrants Granted WarrantsGranted	0	shares
	clbs	Weighted Average Estimated Fair Value Of Restricted Stock WeightedAverageEstimatedFairValueOfRestrictedStock	7.00
	us-gaap	Interest Paid InterestPaid	1122479	USD
	clbs	Weighted Average Estimated Fair Value Of Restricted Stock WeightedAverageEstimatedFairValueOfRestrictedStock	3.10
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	8941452	USD
	clbs	Weighted Average Exercise Price Warrants Canceled WeightedAverageExercisePriceWarrantsCanceled	19.78
	clbs	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised	0.00
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	8568605	USD
	clbs	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired	0.00
	clbs	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted	0.00
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q3	clbs	Weighted Average Exercise Price Warrants Exercisable WeightedAverageExercisePriceWarrantsExercisable	14.06
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2014Q4	clbs	Weighted Average Exercise Price Warrants Outstanding WeightedAverageExercisePriceWarrantsOutstanding	14.12
CY2015Q3	clbs	Weighted Average Exercise Price Warrants Outstanding WeightedAverageExercisePriceWarrantsOutstanding	14.06
CY2015Q3	clbs	Weighted Average Exercise Price Warrantsvestedexpectedtovest WeightedAverageExercisePriceWarrantsvestedexpectedtovest	14.06
CY2014	clbs	Weighted Average Remaining Contractual Termwarrantoutstanding WeightedAverageRemainingContractualTermwarrantoutstanding	P2Y1M13D
	clbs	Weighted Average Remaining Contractual Termwarrantoutstanding WeightedAverageRemainingContractualTermwarrantoutstanding	P1Y4M21D
	clbs	Weighted Average Remaining Contractual Termwarrantsvested WeightedAverageRemainingContractualTermwarrantsvested	P1Y4M21D
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000320017
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55373251	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Caladrius Biosciences, Inc.
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5661173	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2467049	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3111274	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2299817	USD
	us-gaap	Accretion Expense AccretionExpense	7329	USD
	us-gaap	Accretion Expense AccretionExpense	77577	USD
CY2014Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	18260000	USD
CY2015Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	13880000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4322901	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8011205	USD
CY2014Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	4322900	USD
CY2015Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	8011200	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	495400	USD
CY2015Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	523300	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1329	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	878	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	350428903	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	395014267	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3287900	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8941500	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	436500	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8568500	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	385362	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	381588	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	151300	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	302600	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	151300	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	453900	USD
CY2014Q4	us-gaap	Assets Assets	126275392	USD
CY2015Q3	us-gaap	Assets Assets	119702548	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	36281544	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	38481687	USD
CY2015Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	18423300	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	7080000	USD
CY2015Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	5349400	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	19000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	333000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	22358200	USD
CY2015Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	18423300	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	0	USD
CY2015Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	600	USD
CY2014Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	7080100	USD
CY2015Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	5349400	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	0	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis	18424200	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	18424200	USD
CY2015Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	0	USD
CY2014Q2	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	33500000	USD
CY2014Q2	us-gaap	Business Combination Acquired Receivables Fair Value BusinessCombinationAcquiredReceivablesFairValue	45000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1090000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-4380000	USD
CY2014Q2	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh	90000000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	18260000	USD
CY2015Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	13880000	USD
CY2014Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	11900000	USD
CY2014Q4	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	12800000	USD
CY2015Q3	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	13900000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	51000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	201000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent	13901000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1893028	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	34290000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	2014000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	19400000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	1041000	USD
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	33491000	USD
CY2014Q4	us-gaap	Cash Cash	15279400	USD
CY2015Q3	us-gaap	Cash Cash	13074800	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	50894	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46133759	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32141286	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19174061	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24042699	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-13992473	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4868638	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36783857	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55497240	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5329593	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36783857	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55497240	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	36784	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	55497	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16975155	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43261231	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11376937	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-47689557	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-202375	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-514877	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-16908	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-93257	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-17177530	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-43776108	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-11393845	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-47782814	USD
CY2014Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	0.01	shares
CY2015Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	0.01	shares
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	4012369	USD
	us-gaap	Cost Of Revenue CostOfRevenue	11515168	USD
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	4808679	USD
CY2014Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	0	USD
CY2015Q3	us-gaap	Customer Advances Current CustomerAdvancesCurrent	600000	USD
CY2014Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	2566989	USD
CY2015Q3	us-gaap	Deferred Costs Current DeferredCostsCurrent	3348619	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4334120	USD
CY2015Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5498074	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	-3700000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	18176190	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	14566093	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	1300	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	1500	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1578334	USD
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.48
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.37
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.04
CY2014Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	2807200	USD
CY2015Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	3827100	USD
CY2014Q2	us-gaap	Equity Issued In Business Combination Fair Value Disclosure EquityIssuedInBusinessCombinationFairValueDisclosure	21600000	USD
CY2014Q4	us-gaap	Fair Value Estimate Not Practicable Investments FairValueEstimateNotPracticableInvestments	22359500	USD
CY2015Q3	us-gaap	Fair Value Estimate Not Practicable Investments FairValueEstimateNotPracticableInvestments	18424200	USD
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-4380000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2498600	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2952500	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	35134400	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	151300	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	605200	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	605200	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	605200	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	605200	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50059000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	40659000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47560400	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	37706500	USD
CY2014Q4	us-gaap	Goodwill Goodwill	25209336	USD
CY2015Q3	us-gaap	Goodwill Goodwill	25209336	USD
CY2014Q2	us-gaap	Goodwill Goodwill	14092000	USD
CY2015Q3	us-gaap	Goodwill Gross GoodwillGross	25200000	USD
CY2014Q3	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2015Q3	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	9400000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-202375	USD
	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-514877	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-908011	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11346224	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-16907	USD
	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-93257	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17129257	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43634037	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2795249	USD
	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	1000000	USD
	us-gaap	Interest Paid InterestPaid	359300	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-51392460	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47387	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	142183	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46633	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3610097	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	177162	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-815231	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-142183	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	3610097	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1823379	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1163954	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	872079	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	781629	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-559470	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-53743	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	47560406	USD
CY2015Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	37706498	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	183477	USD
	us-gaap	Interest Expense InterestExpense	383539	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	552983	USD
	us-gaap	Interest Expense InterestExpense	1651222	USD
CY2014Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	400000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	900000	USD
CY2015Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	400000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1200000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	68201603	USD
CY2015Q3	us-gaap	Liabilities Liabilities	64706129	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	126275392	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	119702548	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16244582	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	19739942	USD
CY2015Q3	us-gaap	Long Term Debt LongTermDebt	18500000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1109612	USD
CY2015Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	2751425	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	6200000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6700000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5300000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	300000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13890388	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35991241	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-30530623	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	16271458	USD
	us-gaap	Operating Expenses OperatingExpenses	69067514	USD
CY2015Q3	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.030
CY2015Q3	us-gaap	Mortgage Loans On Real Estate Carrying Amount Of Mortgages MortgageLoansOnRealEstateCarryingAmountOfMortgages	3100000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	25546121	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36320417	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3547353	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-921156	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-16258500	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-42187930	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-10383008	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-54139823	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	7403000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1949600	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1034800	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1863800	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2062000	USD
CY2015Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12248575	USD
CY2014Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	825897	USD
CY2015Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	814062	USD
CY2014Q4	us-gaap	Marketable Securities MarketableSecurities	7080053	USD
CY2015Q3	us-gaap	Marketable Securities MarketableSecurities	5349396	USD
CY2014Q4	us-gaap	Marketable Securities Restricted Current MarketableSecuritiesRestrictedCurrent	22359500	USD
CY2015Q3	us-gaap	Marketable Securities Restricted Current MarketableSecuritiesRestrictedCurrent	18424200	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	-441047	USD
CY2015Q3	us-gaap	Minority Interest MinorityInterest	-432937	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16974269	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-43261343	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11375950	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-47689106	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-870757	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1446107	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-963216	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2747363	USD
CY2014Q4	us-gaap	Notes Payable NotesPayable	1600000	USD
CY2015Q3	us-gaap	Notes Payable NotesPayable	1800000	USD
CY2014Q4	us-gaap	Notes Payable Current NotesPayableCurrent	816776	USD
CY2015Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1012189	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	20376283	USD
	us-gaap	Operating Expenses OperatingExpenses	54850220	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	492800	USD
CY2014Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	177200000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	1020300	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-451	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2925918	USD
CY2015Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	3060800	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1263375	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1209632	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	112	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-886	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	112	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-988	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-451	USD
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-886	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	112	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-988	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-451	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	804546	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3457457	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-687280	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1062568	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-410233	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4398585	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	100000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	920329	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	6081900	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2573784	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	100	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	100	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4349167	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3441156	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	11700000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	14476170	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	11275109	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	36136839	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1777163	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1087361	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	248000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	7734528	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	271008	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1720725	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	-17176644	USD
	us-gaap	Profit Loss ProfitLoss	-43776220	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	-11392857	USD
	us-gaap	Profit Loss ProfitLoss	-47782363	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15960731	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17095395	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	737333	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	903783	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	3236721	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8469623	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19024728	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6315613	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20719989	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-291246538	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-338935644	USD
CY2014Q3	us-gaap	Revenues Revenues	4117783	USD
	us-gaap	Revenues Revenues	12662290	USD
CY2015Q3	us-gaap	Revenues Revenues	5888450	USD
	us-gaap	Revenues Revenues	14927691	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7894291	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24310324	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5147166	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24971438	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3516452	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	28600	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	15200	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	13200	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	USD
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	708706	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	811835	shares
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	21600351	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11275109	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	36136839	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	4964000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	2367500	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8941452	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8568605	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	58514836	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	55429356	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	62026435	USD
CY2014Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	62058972	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	58073789	USD
CY2015Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	54996419	USD
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	705742	USD
CY2015Q3	us-gaap	Treasury Stock Value TreasuryStockValue	705742	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	23175	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	35053218	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	31663221	shares
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55239119	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	45867567	shares

Files In Submission

Name	View Source	Status
0000320017-15-000077-index-headers.html	Edgar Link	pending
0000320017-15-000077-index.html	Edgar Link	pending
0000320017-15-000077.txt	Edgar Link	pending
0000320017-15-000077-xbrl.zip	Edgar Link	pending
clbs-10qx20150930.htm	Edgar Link	pending
clbs-20150930.xml	Edgar Link	completed
clbs-20150930.xsd	Edgar Link	pending
clbs-20150930_cal.xml	Edgar Link	unprocessable
clbs-20150930_def.xml	Edgar Link	unprocessable
clbs-20150930_lab.xml	Edgar Link	unprocessable
clbs-20150930_pre.xml	Edgar Link	unprocessable
clbs-ex311_20150930xq3.htm	Edgar Link	pending
clbs-ex312_20150930xq3.htm	Edgar Link	pending
clbs-ex321_20150930xq3.htm	Edgar Link	pending
clbs-ex322_20150930xq3.htm	Edgar Link	pending
exhibit102lsaamendment.htm	Edgar Link	pending
exhibit103commonstockpurch.htm	Edgar Link	pending
exhibit41registrationrights.htm	Edgar Link	pending
exhibit51paulhastingsopini.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta

2015 Q4 Form 10-Q Financial Statement

#000032001715000077 Filed on November 05, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSTA LISATA THERAPEUTICS, INC. Stock $lsta

2015 Q4 Form 10-Q Financial Statement

#000032001715000077 Filed on November 05, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta